Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer's disease neuropathology

Journal of Neural Transmission

Volumn 115, Issue 8, 2008, Pages 1165-1172

  Lai, Mitchell K P ^a,b   Tan, Michelle G K ^a   Kirvell, Sara ^c   Hobbs, Carl ^c   Lee, Jasinda ^b   Esiri, Margaret M ^d   Chen, Christopher P ^b   Francis, Paul T ^c  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid plaque; Neocortex; Neurofibrillary tangle; Purinergic P2Y receptors; Uridine nucleotide

Indexed keywords

PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y4 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; PURINERGIC P2 RECEPTOR; SYNAPTOPHYSIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; MALE; NEOCORTEX; NEUROCHEMISTRY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; OCCIPITAL CORTEX; PARIETAL LOBE; PRIORITY JOURNAL; RECEPTOR DENSITY; SYNAPSE; ANTIBODY SPECIFICITY; COHORT ANALYSIS; GENETICS; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDY; METABOLISM; OCCIPITAL LOBE; PATHOLOGY; PROSPECTIVE STUDY;

AGED; ALZHEIMER DISEASE; ANTIBODY SPECIFICITY; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDIES; MALE; NEUROFIBRILLARY TANGLES; OCCIPITAL LOBE; PARIETAL LOBE; PROSPECTIVE STUDIES; RECEPTORS, PURINERGIC P2; SYNAPTOPHYSIN;

EID: 49749103943     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-008-0067-y     Document Type: Article

References (52)

1. MP Abbracchio G Burnstock JM Boeynaems EA Barnard JL Boyer C Kennedy GE Knight M Fumagalli C Gachet KA Jacobson GA Weisman 2006 International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy Pharmacol Rev 58 281 341
2. 2 receptor activates nerve growth factor/TrkA signaling to enhance neuronal differentiation Proc Natl Acad Sci USA 102 19138 19143
3. DS Auld TJ Kornecook S Bastianetto R Quirion 2002 Alzheimer's disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies Prog Neurobiol 68 209 245
4. C Behl 2000 Apoptosis and Alzheimer's disease J Neural Transm 107 1325 1344
5. H Braak E Braak 1991 Neuropathological stageing of Alzheimer-related changes Acta Neuropathol (Berl) 82 239 259
6. G Burnstock 2007 Physiology and pathophysiology of purinergic neurotransmission Physiol Rev 87 659 797
7. D Butler J Bendiske ML Michaelis DA Karanian BA Bahr 2007 Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers Eur J Pharmacol 562 20 27
8. 6 and atypical UTP-sensitive receptors coupled to rises in intracellular calcium in mouse cultured superior cervical ganglion neurons and glia Br J Pharmacol 143 525 532
9. 2 nucleotide receptors enhance α-secretase-dependent amyloid precursor protein processing J Biol Chem 280 18696 18702
10. 4 receptor during hypoglycemia: cross talk with the ionotropic NMDAR1 receptor Exp Cell Res 300 149 158
11. 4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells Neurobiol Dis 18 100 109
12. G Cole KR Dobkins LA Hansen RD Terry T Saitoh 1988 Decreased levels of protein kinase C in Alzheimer brain Brain Res 452 165 174
13. SE Counts EJ Mufson 2005 The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease J Neuropathol Exp Neurol 64 263 272
14. AJ Cross TJ Crow IN Ferrier JA Johnson 1986 The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia Neurobiol Aging 7 3 7
15. JL Cummings C Back 1998 The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease Am J Geriatr Psychiatry 6 S64 S78
16. DD Flynn DA Weinstein DC Mash 1991 Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies Ann Neurol 29 256 262
17. MF Folstein SE Folstein PR McHugh 1975 Mini-mental state. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 189 198
18. PT Francis 2003 Glutamatergic systems in Alzheimer's disease Int J Geriatr Psychiatry 18 S15 S21
19. PT Francis NR Sims AW Procter DM Bowen 1993 Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives J Neurochem 60 1589 1604
20. PT Francis AM Palmer M Snape GK Wilcock 1999 The cholinergic hypothesis of Alzheimer's disease: a review of progress J Neurol Neurosurg Psychiatry 66 137 147
21. FA Gonzalez GA Weisman L Erb CI Seye GY Sun B Velazquez M Hernandez-Perez NE Chorna 2005 Mechanisms for inhibition of P2 receptors signaling in neural cells Mol Neurobiol 31 65 79
22. JA Hardy P Wester B Winblad C Gezelius G Bring A Eriksson 1985 The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue J Neural Transm 61 253 264
23. E Hellstrom-Lindahl 2000 Modulation of β-amyloid precursor protein processing and τ phosphorylation by acetylcholine receptors Eur J Pharmacol 393 255 263
24. T Hope J Keene C Fairburn R McShane R Jacoby 1997 Behaviour changes in dementia. 2: Are there behavioural syndromes? Int J Geriatr Psychiatry 12 1074 1078
25. T Hope J Keene K Gedling S Cooper C Fairburn R Jacoby 1997 Behaviour changes in dementia. 1: Point of entry data of a prospective study Int J Geriatr Psychiatry 12 1062 1073
26. T Hope J Keene CG Fairburn R Jacoby R McShane 1999 Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease. A longitudinal study Br J Psychiatry 174 39 44
27. S Hussl S Boehm 2006 Functions of neuronal P2Y receptors Pflugers Arch 452 538 551
28. EH Jacobs RJ Williams PT Francis 2006 Cyclin-dependent kinase 5, Munc18a and Munc18-interacting protein 1/X11α protein up-regulation in Alzheimer's disease Neuroscience 138 511 522
29. 4 nucleotide receptors Biochem Pharmacol 65 923 931
30. SL Kirvell M Esiri PT Francis 2006 Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease J Neurochem 98 939 950
31. 2 binding in the cortex Neurology 57 805 811
32. 2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease Psychopharmacology (Berl) 179 673 677
33. A Lanari F Amenta G Silvestrelli D Tomassoni L Parnetti 2006 Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease Mech Ageing Dev 127 158 165
34. KL Lanctot N Herrmann P Mazzotta 2001 Role of serotonin in the behavioral and psychological symptoms of dementia J Neuropsychiatry Clin Neurosci 13 5 21
35. CJ Lee G Mannaioni H Yuan DH Woo MB Gingrich SF Traynelis 2007 Astrocytic control of synaptic NMDA receptors J Physiol 581 1057 1081
36. JP Lerch JC Pruessner A Zijdenbos H Hampel SJ Teipel AC Evans 2005 Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy Cereb Cortex 15 995 1001
37. DM Mann 1996 Pyramidal nerve cell loss in Alzheimer's disease Neurodegeneration 5 423 427
38. JG McLarnon HB Choi LF Lue DG Walker SU Kim 2005 Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients J Neurosci Res 81 426 435
39. 2C receptors in learning Behav Brain Res 87 105 110
40. SS Mirra A Heyman D McKeel SM Sumi BJ Crain LM Brownlee FS Vogel JP Hughes G van Belle L Berg 1991 The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology 41 479 486
41. 1 purinergic receptor in Alzheimer's disease Neuroreport 11 3799 3803
42. RA Nicholas WC Watt ER Lazarowski Q Li K Harden 1996 Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor Mol Pharmacol 50 224 229
43. RM Nitsch BE Slack RJ Wurtman JH Growdon 1992 Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors Science 258 304 307
44. 2c receptors stimulate amyloid precursor protein ectodomain secretion J Biol Chem 271 4188 4194
45. RC Pearson TP Powell 1989 The neuroanatomy of Alzheimer's disease Rev Neurosci 2 101 121
46. E Sadot D Gurwitz J Barg L Behar I Ginzburg A Fisher 1996 Activation of m1 muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells J Neurochem 66 877 880
47. DJ Selkoe 2001 Alzheimer's disease: genes, proteins, and therapy Physiol Rev 81 741 766
48. SW Tsang MK Lai S Kirvell PT Francis MM Esiri T Hope CP Chen PT Wong 2006 Impaired coupling of muscarinic M(1) receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease Neurobiol Aging 27 1216 1223
49. SW Tsang J Pomakian GA Marshall HV Vinters JL Cummings CP Chen PT Wong MK Lai 2007 Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease Neurobiol Aging 28 1381 1387
50. 2 receptor activation regulates the expression of acetylcholinesterase and acetylcholine receptor genes at vertebrate neuromuscular junctions Mol Pharmacol 66 794 806
51. PJ Whitehouse DL Price RG Struble AW Clark JT Coyle MR Delon 1982 Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain Science 215 1237 1239
52. K Wirkner A Gunther M Weber SJ Guzman T Krause J Fuchs L Koles W Norenberg P Illes 2007 Modulation of NMDA receptor current in layer V pyramidal neurons of the rat prefrontal cortex by P2Y receptor activation Cereb Cortex 17 621 631